Clinical trial
Relationship Between Red Blood Cell Distribution Width-to-albumin Ratio and Major Adverse Cardiovascular Events in Acute Myocardial Infarction Complicated With Cardiogenic Shock Patients During Hospitalization
NCT07507110 is registered in ClinicalTrials.gov with Xuzhou Central Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Relationship Between Red Blood Cell Distribution Width-to-albumin Ratio and Major Adverse Cardiovascular Events in Acute Myocardial Infarction Complicated With Cardiogenic Shock Patients During Hospitalization
- Lead sponsor
- Xuzhou Central Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 1, 2019
- Completion date
- December 31, 2025
- Enrollment
- 264 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute myocardial infarction (ami), major adverse cardiovascular events, red blood cell distribution width-to-albumin ratio